Azienda Ospedaliera Sant'Andrea
Rome, 00188, Italy
NCT Number: NCT04752241
This study aims to evaluate whether IMA sparing may represent an advantage in terms of reduced incidence and severity of sexual dysfunctions after colorectal resections for diverticular disease (DD).
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Rome, 00188, Italy
Enrolled patients were randomly divided into 2 treatment groups. In the first group (IMAP) the IMA was preserved sectioning the sigmoid arteries near colonic wall while, in the second group (IMAS) the IMA was sectioned immediately below the origin of the left colic artery. Incidence and severity of sexual dysfunction and QoL were assessed by four validated questionnaire administered 6,12 months and 5 and 8 years after surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Performing left hemicolectomy the IMA was preserved ligating close to the colonic wall the sigmoids arteries.
Performing left hemicolectomy the IMA is ligated and sectioned after the origin of left colic artery
Time frame: 12 months after surgery
Presence of sexual disfunction ( defined through the evaluation of sexual desire ,arousal, lubrication , orgasmic function, overall satisfaction, pain, intercourse satisfaction , erectile function)
Time frame: 6 years after surgery
Presence of sexual disfunction ( defined through the evaluation of sexual desire ,arousal, lubrication , orgasmic function, overall satisfaction, pain, intercourse satisfaction , erectile function)
Time frame: 12 month after surgery
assess the patients' sexual disorders with International Index of Erectile Function (IIEF) 15-items test
Time frame: 6 years after surgery
assess the patients' sexual disorders with International Index of Erectile Function (IIEF) 15-items test
Time frame: 12 months after surgery
assess the patients' sexual disorders withFemale Sexual Function Index (FSFI) a 19-item test (score below 26.55 indicates the presence of sexual dysfunctions)
Time frame: 6 years after surgery
assess the patient's sexual disorders with Female Sexual Function Index (FSFI) 19-item test (score below 26.55 indicates the presence of sexual dysfunctions)
Time frame: 12 months after surgery
The impact of sexual disorders in QoL was evaluated using EORTC QLQ-30 ( European organisation for research and treatment of cancer- quality of life questionnaire)
Time frame: 6 years after surgery
The impact of sexual disorders in QoL was evaluated using EORTC QLQ-30( European organisation for research and treatment of cancer- quality of life questionnaire)
Time frame: 12 months after surgery
The impact of sexual disorders in QoL was evaluated using SF-36 score (Short Form Health Survey 36)
Time frame: 6 years after surgery
The impact of sexual disorders in QoL was evaluated using SF- 36 score ( Short Form Health Survey 36 )
University of Roma La Sapienza
Other
Acronym: IMAPSEX
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07296796
Behavior, Death
London, United Kingdom
View Trial DetailsNCT05342090
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Calgary, Alberta, Canada
View Trial DetailsNCT05707429
Digestive System Diseases, Gastroenteritis
Asyut, Egypt
View Trial DetailsNCT06231433
Connective Tissue Diseases, Mental Disorders
Milan, Italy
View Trial Details